The effects of dexmedetomidine on postoperative tumor recurrence and patient survival after breast cancer surgery: a feasibility study

• Published in: ANESTHESIOLOGY AND PERIOPERATIVE SCIENCE Vol. 1; no. 4; pp. 1 - 12
• Main Authors: Luo, Jiamei, Xuan, Wei, Sun, Jiaxin, Wang, Xiaoqiang, Shi, Yumiao, Zhang, Yiqi, Yin, Wenjin, Shu, Huigang, Lu, Jinsong, Tian, Jie
• Format: Journal Article
• Language: English
• Published: Singapore Springer Nature Singapore 24.11.2023; Springer
• Subjects: Anesthesiology; Breast cancer; Critical Care Medicine; Dexmedetomidine; Intensive; Medicine; Medicine & Public Health; Neurosciences; Original Research; Overall survival; Pharmacology/Toxicology; Recurrence-free survival; Surgery; Breast cancer; Recurrence-free survival; Overall survival; Dexmedetomidine

Purpose Dexmedetomidine (Dexmed) is a highly selective alpha 2 adrenoceptor (α 2 -AR) agonist with excellent sedation and analgesic effects and is frequently used in breast cancer surgery. However, the exact impact of Dexmed on breast cancer prognosis is still unclear. The primary objective of this...